Greater Cannabis Company (GCAN) Other Non-Current Liabilities (2016 - 2021)

Greater Cannabis Company (GCAN) recorded quarterly Other Non-Current Liabilities of $260905.0 in Q1 2021, up 1395.93% quarter-over-quarter from $17441.0 in Q4 2020, and down 84.69% on a YoY basis from $1.7 million in Q1 2020.

Greater Cannabis Company (GCAN) Other Non-Current Liabilities (2016 - 2021) Analysis & Trends

Greater Cannabis Company's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $260905.0 for Q1 2021.

  • In Q1 2021, Other Non-Current Liabilities fell 84.69% year-over-year to $260905.0; the TTM figure through Mar 2021 stood at $260905.0 (down 84.69% YoY), while the FY2020 annual figure was $17441.0, changed 0.0% from the prior year.
  • Other Non-Current Liabilities was $260905.0 for Q1 2021 at Greater Cannabis Company, up from $17441.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.7 million in Q1 2020 to a low of $17441.0 in Q4 2019.
  • Historically, Other Non-Current Liabilities has averaged $343527.9 across 5 years, with a median of $259142.0 in 2018.
  • The sharpest annual moves came in 2020 and 2021: Other Non-Current Liabilities jumped 411.19% in 2020, then sank 84.69% in 2021.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $205403.0 in 2017, then sank by 47.21% to $108427.0 in 2018, then plunged by 83.91% to $17441.0 in 2019, then changed by 0.0% to $17441.0 in 2020, then jumped by 1395.93% to $260905.0 in 2021.
  • The last three Other Non-Current Liabilities figures came in at $260905.0 (Q1 2021), $17441.0 (Q4 2020), and $325935.0 (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Greater Cannabis Company - - -

Historic Data

Download Data
DateValue
Mar 31, 2021 260,905.00
Dec 31, 2020 17,441.00
Sep 30, 2020 325,935.00
Jun 30, 2020 539,686.00
Mar 31, 2020 1.70 Mn
Dec 31, 2019 17,441.00
Sep 30, 2019 251,367.00
Jun 30, 2019 251,367.00
Mar 31, 2019 333,432.00
Dec 31, 2018 108,427.00
Sep 30, 2018 482,667.00
Jun 30, 2018 270,502.00
Mar 31, 2018 259,142.00
Dec 31, 2017 205,403.00
Sep 30, 2017 124,731.00
Dec 31, 2016 100,000.00